Medistim ASA

MEDI · Oslo Børs · Healthcare

250.00NOK −1.2%last day

Price as of 2 October 2026

The price over the past year, with dividends: +13.6%

Performance

1 month

−0.4%

1 year

+13.6%

3 years, per year

+8.8%

5 years, per year

−2.5%

Largest fall, 3 years

−64.6%

Below the peak now

−28.8%

Volatility, 1 year

36.0%

Return with dividends reinvested.

Key figures

P/E

28.4

P/B

11.4

Dividend yield

3.2%

Return on equity

+40.2%

Net margin

+22.0%

Market value

474 m USD

Quality, value and trend

Where Medistim stands against every Nordic stock today. 100 is best.

Quality100

Profitability and a sound balance sheet over time. Better than 100% of Nordic stocks.

Value14

The price measured against earnings, assets and cash flow. Better than 14% of Nordic stocks.

Trend77

The price development over the past year. Better than 77% of Nordic stocks.

Combined75

Quality, value and trend together. Better than 75% of Nordic stocks.

About Medistim

Medistim ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 160 employees.

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis